Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity

Oncogene

Volumn 18, Issue 27, 1999, Pages 4044-4046

  Legoix, Patricia ^a   Bluteau, Olivier ^a   Bayer, Jan ^a,b   Perret, Christine ^c   Balabaud, Charles ^d   Belghiti, Jacques ^e   Franco, Dominique ^f   Thomas, Gilles ^a   Laurent Puig, Pierre ^a   Zucman Rossi, Jessica ^a  

^a INSERM   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c Université Paris Descartes   (France)

^d HÔPITAL SAINT ANDRÉ   (France)

^e BEAUJON HOSPITAL   (France)

^f HÔPITAL ANTOINE BÉCLÈRE   (France)

Author keywords

Allelic losses; APC; Beta catenin; Chromosome 4; CNNTB1; Hepatocellular carcinoma; Mutation

Indexed keywords

BETA CATENIN;

ADULT; AGED; ARTICLE; CHROMOSOME 16P; CHROMOSOME 1P; CHROMOSOME 4Q; COLON POLYPOSIS; FEMALE; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANEUPLOIDY; BETA CATENIN; CADHERINS; CARCINOMA, HEPATOCELLULAR; CYTOSKELETAL PROTEINS; DNA MUTATIONAL ANALYSIS; DROSOPHILA PROTEINS; GENES, APC; HUMANS; LIVER NEOPLASMS; LOSS OF HETEROZYGOSITY; MUTATION; PROTO-ONCOGENE PROTEINS; TRANS-ACTIVATORS; WNT PROTEINS; ZEBRAFISH PROTEINS;

EID: 0033536185     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202800     Document Type: Article

References (20)

1. Bardi G, Johannson B, Pandis N, Heim S, Mandahl N, Andren-Sandberg A, Hagerstrand I and Mitelman F. (1992). Cancer Genet. Cytogenet., 58, 191-195.
2. Boige V, Laurent-Puig P, Fouchet P, Flejou JF, Monges G, Bedossa P, Bioulac-Sage P, Capron F, Schmitz A, Olschwang S and Thomas G. (1997). Cancer Res., 57, 1986-1990.
3. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR and Ozturk M. (1990). Proc. Natl. Acad. Sci. USA, 87, 1973-1977.
4. De La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A and Perret C. (1998). Proc. Natl. Acad. Sci. USA, 95, 8847-8851.
5. De Souza AT, Hankins GR, Washington MK, Orton TC and Jirtle RL. (1995). Nat. Genet., 11, 447-449.
6. De Thé H, Marchio A, Tiollais P and Dejean A. (1987). Nature, 330, 667-670.
7. Graef E, Caselmann WH, Wells J and Koshy R. (1994). Oncogene, 9, 81-87.
8. Iwao K, Nakamori S, Kameyama M, Imaoka S, Kinoshita M, Fukui T, Ishiguro S, Nakamura Y and Miyoshi Y. (1998). Cancer Res., 58, 1021-1026.
9. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A and Dejean A. (1997). Genes Chromo Cancer, 18, 59-65.
10. Miyoshi Y, Iwao K, Nagasawa Y, Aihara T, Sasaki Y, Imaoka S, Murata M, Shimano T and Nakamura Y. (1998). Cancer Res., 58, 2524-2527.
11. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B and Kinzler KW. (1997). Science, 275, 1787-1790.
12. Nagai H, Pineau P, Tiollais P, Buendia MA and Dejean A. (1997). Oncogene, 14, 2927-2933.
13. Olschwang S, Hamelin R, Laurent-Puig P, Thuille B, De Rycke Y, Li YJ, Muzeau F, Girodet J, Salmon RJ and Thomas G. (1997). Proc. Natl. Acad. USA, 94, 12122-12127.
14. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E and Polakis P. (1997). Science, 275, 1790-1792.
15. Simon D, Munoz SJ, Maddrey WC and Knowles BB. (1990). Cancer Genet. Cytogenet., 45, 255-260.
16. Sparks AB, Morin PJ, Vogelstein B and Kinzler KW. (1998). Cancer Res., 58, 1130-1134.
17. Tada M, Omata M and Ohto M. (1990). Cancer Res., 50, 1121-1124.
18. Takahashi M, Fukuda K, Sugimura T and Wakabayashi K. (1998). Cancer Res., 58, 42-46.
19. Wang J, Chenivesse X, Henglein B and Brechot C. (1990). Nature, 343, 555-557.
20. Zeng L, Fagotto F, Zhang T, Hsu W, Vasicek TJ, Perry WL, Lee JJ, Tilghman SM, Gumbiner BM and Costantini F. (1997). Cell, 90, 181-192.